KR101331734B1 - Toothpaste composition - Google Patents

Toothpaste composition Download PDF

Info

Publication number
KR101331734B1
KR101331734B1 KR1020087004645A KR20087004645A KR101331734B1 KR 101331734 B1 KR101331734 B1 KR 101331734B1 KR 1020087004645 A KR1020087004645 A KR 1020087004645A KR 20087004645 A KR20087004645 A KR 20087004645A KR 101331734 B1 KR101331734 B1 KR 101331734B1
Authority
KR
South Korea
Prior art keywords
mass
sodium
composition
toothpaste
gum
Prior art date
Application number
KR1020087004645A
Other languages
Korean (ko)
Other versions
KR20080074087A (en
Inventor
치하루 키타가와
코우이치 스가와라
Original Assignee
라이온 가부시키가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 라이온 가부시키가이샤 filed Critical 라이온 가부시키가이샤
Publication of KR20080074087A publication Critical patent/KR20080074087A/en
Application granted granted Critical
Publication of KR101331734B1 publication Critical patent/KR101331734B1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/24Phosphorous; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/55Phosphorus compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/46Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/46Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
    • A61K8/463Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur containing sulfuric acid derivatives, e.g. sodium lauryl sulfate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/81Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
    • A61K8/8164Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a carboxyl radical, and containing at least one other carboxyl radical in the molecule, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers, e.g. poly (methyl vinyl ether-co-maleic anhydride)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses

Abstract

(A) 일반식 Mn +2PnO3n +1(단, 식중, M은 Na 또는 K를 나타내고, n은 2 또는 3의 정수이다)로 표시되는 직쇄상의 수용성 폴리인산염의 적어도 1종을 0.3 내지 1.2질량%, (B) 25℃, pH7.0에서의 2.0질량% 수용액의 점도가 5 내지 1000mPa·s인 메틸비닐에테르 무수 말레인산 공중합체를 0.1 내지 2.0질량%, (C) 라우릴황산염을 0.6 내지 2.0질량%, (D) 베타인형 양성 계면활성제 0.2 내지 1.0질량%를 함유하고, 또한 (C)/(D)의 배합 비율이 질량비로 1 내지 4인 것을 특징으로 하는 치약 조성물. 이 치약 조성물은, 구강 점막에 대한 자격(刺激)이 거의 없고, 사용시의 거품 생김에 우수하고, 또한 치면 오염에 대한 부착 억제 효과에 우수하다.(A) at least one linearly water-soluble polyphosphate represented by the general formula M n +2 P n O 3n +1 (wherein M represents Na or K and n is an integer of 2 or 3); 0.3-1.2 mass%, (B) 0.1-2.0 mass% of the methylvinyl ether maleic anhydride copolymer whose viscosity of 2.0 mass% aqueous solution in 25 degreeC and pH7.0 is 5-1000 mPa * s, and (C) lauryl A dentifrice composition comprising 0.6-2.0 mass% of sulfate, 0.2-1.0 mass% of (D) betaine type amphoteric surfactant, and the compounding ratio of (C) / (D) is 1-4 by mass ratio. This toothpaste composition is hardly qualified for the oral mucosa, is excellent in foaming at the time of use, and excellent in the effect of inhibiting adhesion to tooth surface contamination.

치약 조성물Toothpaste composition

Description

치약 조성물{TOOTHPASTE COMPOSITION}Toothpaste composition {TOOTHPASTE COMPOSITION}

본 발명은, 구강(口腔)점막에 대한 자격(刺激)이 거의 없고, 사용시의 거품 생김(泡立)에 우수하고, 또한 치면 오염에 대한 부착 억제 효과에 우수한 치약 조성물에 관한 것이다.The present invention relates to a dentifrice composition which is hardly qualified for the oral mucosa, is excellent in foaming during use, and is excellent in the effect of inhibiting adhesion to tooth surface contamination.

담뱃진이나 차앙금(茶澁))등으로 착색한 이빨을 하얗게 하기 위해, 종래로 부터 다양한 방법이 검토되어 오고 있다. 예를 들면, 고연마성 연마제의 사용이나, 과산화물에 의한 백색화, 폴리에틸렌글리콜 등에 의한 담뱃진의 용해 제거, 키레이트제에 의한 철(鐵)이온 등의 제거, 재석회화(再石灰化)에 의한 치면의 평활화 등이 일반적이다.Various methods have been studied in the past in order to whiten teeth which have been colored with cigarettes or chalcedony. For example, use of highly abrasive abrasives, whitening with peroxides, dissolving and removing of tobacco with polyethylene glycol, removal of iron ions with a chelating agent, and tooth surface by remineralization The smoothing of the is common.

그러나, 고연마성 연마제의 사용은 치아를 손상시킬 우려가 있고, 폴리에틸렌글리콜 등으로는 치석과 같은 완고한 착색 오염의 용해 제거 효과는 불충분하다. 또한, 과산화물에 의한 방법도, 에나멜질 표면의 유기물이 탈각(脫却)하여 내산성이 저하되는 등의 문제점도 지적되어, 우리 나라에서는 치과의사(齒科醫)만이 가능한 처치로 되어 있는 것이 현재의 상태이다.However, the use of a high abrasive abrasive may damage teeth, and polyethylene glycol or the like has insufficient effect of dissolving and removing stubborn stains such as tartar. In addition, the method using peroxide also causes problems such as demineralization of organic matter on the enamel surface and deterioration of acid resistance. Therefore, the present invention is a treatment that only a dentist can use in our country. It is a state.

종래, 피로인산 나트륨 등의 직쇄상 폴리인산염은, 치석 예방이나 이빨의 오염을 제거하는 성분으로서 공지되어 있고, 구강용 조성물에 배합되어 있다(특허 문 헌 1, 2, 3 참조). 또한, 수용성 폴리인산염과 메틸비닐에테르 무수 말레인산 공중합체를 포함하는 합성 음이온 선상(線狀) 고분자 폴리카르복실레이트와 라우릴황산염을 배합한 치석(齒石)방지 구강용 조성물도 보고되고 있다(특허 문헌 4, 5, 6, 7, 8, 9, 10, 11 참조). 이들의 제안에서는, 예를 들면 피로인산 나트륨 등의 수용성 폴리인산염을 1.5질량% 이상과 라우릴황산염을 1.2질량% 이상 포함하는 조성이 제안되고 있고, 구강 점막에 대해 강한 자격이 생긴다는 문제점이 있다.Conventionally, linear polyphosphate, such as sodium pyrophosphate, is known as a component for preventing tartar and removing contamination of teeth, and is incorporated into a composition for oral cavity (see Patent Documents 1, 2 and 3). In addition, there has been reported a composition for preventing dental plaque comprising a synthetic anionic linear polymer polycarboxylate and lauryl sulfate containing a water-soluble polyphosphate and a methyl vinyl ether maleic anhydride copolymer (patent) References 4, 5, 6, 7, 8, 9, 10, 11). In these proposals, for example, a composition containing 1.5% by mass or more of water-soluble polyphosphate such as sodium pyrophosphate and 1.2% by mass or more of lauryl sulfate is proposed, and there is a problem that strong qualification is generated for the oral mucosa. .

한편, 특허 문헌 12에서는, 실시예 1로서 메틸비닐에테르 무수 말레인산 공중합체(상품명 : 간토레츠 S-97)를 13.6질량%, 피로인산 나트륨을 0.125질량%, 라우릴황산염을 0.945질량% 배합한 조성물이 기재되어 있지만, 이 조성에서는 피로인산 나트륨의 배합 농도가 낮기 때문에, 치면 오염에 대한 부착 억제 효과를 얻을 수 없다.In addition, in patent document 12, the composition which mix | blended 13.6 mass% of methylvinyl ether maleic anhydride copolymers (brand name: Gantoretsu S-97), 0.125 mass% of sodium pyrophosphate, and 0.945 mass% of lauryl sulfate as Example 1 Although this is described, since the compounding concentration of sodium pyrophosphate is low in this composition, the effect of suppressing adhesion to tooth surface contamination cannot be obtained.

또한, 특허 문헌 10에서는, 실시예 1로서 메틸비닐에테르 무수 말레인산 공중합체(상품명 : 간토레츠 S-97)를 15질량%, 피로인산 나트륨을 0.25질량%, 라우릴황산염을 0.75질량% 배합한 조성이 기재되어 있지만, 조성물중의 피로인산 나트륨 및 계면활성제량의 배합량이 적고, 사용시의 거품이 잘 일지 않고, 또한 치면 오염에 대한 부착 억제 효과도 얻을 수 없다.In addition, in patent document 10, the composition which mix | blended 15 mass% of methylvinyl ether maleic anhydride copolymers (brand name: Kantoretsu S-97), 0.25 mass% of sodium pyrophosphate, and 0.75 mass% of lauryl sulfate as Example 1 is carried out. Although this is described, the compounding quantity of sodium pyrophosphate and surfactant amount in a composition is small, the foam | bubble at the time of use does not form well, and also the effect of suppressing adhesion to tooth contamination is not acquired.

이와 같이 종래 기술에서는, 치면 오염에 대한 우수한 부착 억제 효과를 가지며, 구강 점막에 대해 저자격이고, 또한 사용시의 거품 생김에 우수하고, 이들 특성의 전부를 만족하는 치약 조성물은 얻어지지 않는 것이 현재의 상태이고, 이들의 과제를 극복하는 치약 조성물의 개발이 요망되고 있다.As described above, in the prior art, toothpaste compositions having excellent adhesion inhibitory effect on tooth surface contamination, being hypoallergenic to the oral mucosa and excellent in foaming at the time of use, and satisfying all of these characteristics, have not been obtained. It is a state and development of the toothpaste composition which overcomes these subjects is desired.

특허 문헌 1 : 일본 특개평9-175966호 공보Patent Document 1: Japanese Patent Application Laid-Open No. 9-175966

특허 문헌 2 : 일본 특개평10-182389호 공보Patent Document 2: Japanese Patent Application Laid-Open No. 10-182389

특허 문헌 3 : 일본 특개평11-343220호 공보Patent Document 3: Japanese Patent Application Laid-Open No. 11-343220

특허 문헌 4 : 일본 특개평2-4708호 공보Patent Document 4: Japanese Patent Application Laid-Open No. 2-4708

특허 문헌 5 : 일본 특개평4-270210호 공보Patent Document 5: Japanese Patent Application Laid-Open No. 4-270210

특허 문헌 6 : 일본 특공평8-18961호 공보Patent Document 6: Japanese Patent Application Laid-Open No. 8-18961

특허 문헌 7 : 일본 특허 제2528492호 공보Patent Document 7: Japanese Patent No. 2528492

특허 문헌 8 : 일본 특표평11-506104호 공보Patent Document 8: Japanese Patent Laid-Open No. 11-506104

특허 문헌 9 : 일본 특개2002-316920호 공보Patent Document 9: Japanese Patent Application Laid-Open No. 2002-316920

특허 문헌 10 : 일본 특개2002-526394호 공보Patent Document 10: Japanese Patent Application Laid-Open No. 2002-526394

특허 문헌 11 : 일본 특표2004-517833호 공보Patent Document 11: Japanese Patent Application Laid-Open No. 2004-517833

특허 문헌 12 : 일본 특표2002-500174호 공보Patent Document 12: Japanese Patent Application Laid-Open No. 2002-500174

본 발명은, 상기 사정을 감안하여 이루어진 것으로, 구강 점막에 대해 저자격이고, 이 닦을 때의 입 안에서의 거품 생김도 양호하고, 또한 우수한 치면 오염에 대한 부착 억제 효과를 갖는 치약 조성물을 제공하는 것을 목적으로 하는 것이다.The present invention has been made in view of the above circumstances, and it is hypoallergenic to the oral mucosa and provides a toothpaste composition having good foaming in the mouth when brushing and having an excellent anti-adhesion effect against tooth contamination. It is for the purpose.

과제를 해결하기 위한 수단Means for solving the problem

본 발명자는, 상기 목적을 달성하기 위해 예의 연구를 거듭한 결과, 치면 오염의 부착 억제를 위해 (A)직쇄상의 수용성 폴리인산염, (B) 25℃, pH7.0에서의 2.0질량% 수용액의 점도가 5 내지 1000mPa·s인 메틸비닐에테르 무수 말레인산 공중합체, (C) 라우릴황산염을 배합하고, 또한, 구강 점막에 대해 저자격이고, 또한 사용시에 우수한 거품 생김을 확보하기 위해 (D)베타인형 양성(兩性) 계면활성제를 (C)/(D)의 배합 비율이 질량비로 1 내지 4가 되도록 배합하고, 특히, 수용성 폴리인산염은 라우릴황산염과의 병용 배합 조성에서는 1.2질량%를 초과하면 구강 점막에 대해 자격이 생기기 때문에, (A)성분인 수용성 폴리인산염을 0.3 내지 1.2질량%, (B)성분인 메틸비닐에테르 무수 말레인산 공중합체를 0.1 내지 2.0질량%, (C)성분인 라우릴황산염을 0.6 내지 2.0질량%, (D)성분인 베타인형 양성 계면활성제를 0.2 내지 1.0질량% 배합하고, 또한 (C)/(D)를 상기 비율로 함으로써, 구강 점막에 대해 저자격이며, 치면 오염에 대한 부착 억제 효과가 상승적으로 높아지고, 또한 이를 닦을 때에 우수한 거품 생김을 얻을 수 있는 것을 발견하고, 본 발명을 이루게 된 것이다.MEANS TO SOLVE THE PROBLEM As a result of earnestly researching in order to achieve the said objective, in order to suppress adhesion of tooth surface contamination, this inventor carried out (A) linear water-soluble polyphosphate, (B) of 25 mass% aqueous solution in 25 degreeC, pH7.0. (D) Beta to mix methylvinyl ether maleic anhydride copolymer having a viscosity of 5 to 1000 mPa · s and (C) lauryl sulfate, and also to be hypoallergenic to the oral mucosa and to ensure excellent foaming in use. When the doll-positive surfactant is blended so that the blending ratio of (C) / (D) is 1 to 4 by mass ratio, in particular, the water-soluble polyphosphate is more than 1.2% by mass in the combined composition with lauryl sulfate. Since qualification occurs about the oral mucosa, 0.3-1.2 mass% of water-soluble polyphosphate which is (A) component, 0.1-2.0 mass% of methyl vinyl ether maleic anhydride copolymer which is (B) component, and lauryl which is (C) component 0.6-2.0 mass% of sulfates, (D) component By mixing 0.2-1.0 mass% of betaine type amphoteric surfactant and making (C) / (D) the said ratio, it is hypoallergenic with respect to oral mucosa, and the effect of inhibiting adhesion to tooth contamination is synergistically increased, and It was found that excellent foaming can be obtained when wiping, and the present invention has been achieved.

따라서 본 발명은, (A) 일반식 Mn +2PnO3n +1(단, 식중, M은 Na 또는 K를 나타내고, n은 2 또는 3의 정수이다)로 표시되는 직쇄상의 수용성 폴리인산염의 적어도 1종을 0.3 내지 1.2질량%, (B) 25℃, pH7.0에서의 2.0질량% 수용액의 점도가 5 내지 1000mPa·s인 메틸비닐에테르 무수 말레인산 공중합체를 0.1 내지 2.0질량%, (C) 라우릴황산염을 0.6 내지 2.0질량%, (D)베타인형 양성 계면활성제 0.2 내지 1.0질량%를 함유하며, 또한 (C)/(D)의 배합 비율이 질량비로 1 내지 4인 것을 특징으로 하는 치약 조성물, 및, 또한, 연마제를 5 내지 50질량%, 점조제를 10 내지 50질량%, 및 증점제를 0.1 내지 5질량% 배합하고, 크림치약(練齒磨) 조성물로서 조제된 상기한 치약 조성물을 제공한다.Accordingly, the present invention, (A) the general formula M n +2 P n O 3n +1 soluble poly straight chain represented by the following (note that the formula, M is Na or K represents an, n is an integer of 2 or 3) 0.1-2.0 mass% of methylvinyl ether maleic anhydride copolymer whose viscosity is 2.0-1000 mass% aqueous solution in 0.3-1.2 mass%, (B) 25 degreeC, pH7.0 in at least 1 sort (s) of phosphate, (C) 0.6-2.0 mass% of lauryl sulfate, 0.2-1.0 mass% of (D) betaine-type amphoteric surfactant, and the compounding ratio of (C) / (D) is 1-4 by mass ratio, It is characterized by the above-mentioned. Toothpaste composition which consists of and the above toothpaste prepared as a cream toothpaste composition by mix | blending 5-50 mass% of abrasives, 10-50 mass% of viscous agents, and 0.1-5 mass% of thickeners. To provide a composition.

발명의 효과Effects of the Invention

본 발명의 치약 조성물은, 구강 점막에 대해 저자격성이며, 사용시에 충분한 거품 생김을 얻을 수 있고, 또한 우수한 치면 오염에 대한 부착 억제 효과를 발현시킬 수 있다.The dentifrice composition of the present invention is hypoallergenic with respect to the oral mucosa, can obtain sufficient foaming at the time of use, and can express an effect of inhibiting adhesion to tooth surface contamination.

이하, 본 발명에 대해 더욱 상세히 설명하면, 본 발명의 치약 조성물은, (A)직쇄상의 수용성 폴리인산염, (B)메틸비닐에테르 무수 말레인산 공중합체, (C)라우릴황산염 및 (D)베타인형 양성 계면활성제를 함유하는 것이다.Hereinafter, the present invention will be described in more detail, the toothpaste composition of the present invention, (A) linear water-soluble polyphosphate, (B) methyl vinyl ether maleic anhydride copolymer, (C) lauryl sulfate and (D) beta It contains a doll amphoteric surfactant.

본 발명의 치약 조성물에 사용되는 (A)성분인 수용성 폴리인산염은, 일반식 Mn+2PnO3n+1(단, 식중, M은 Na 또는 K를 나타내고, n은 2 또는 3의 정수이다)로 표시된다.Component (A) is a water-soluble polyphosphates for use in dentifrice compositions of the present invention represented by the general formula M n + 2 P n O 3n + 1 ( stage, wherein, M represents a Na or K, n is 2 or 3 constant of Is displayed.

구체적인 화합물로서는, 중합도(n)=2의 피로인산 나트륨(태평화학산업(주)제 등)이나 피로인산 칼륨(태평화학산업(주)제 등), n=3의 트리폴리인산 나트륨(센트럴유리(주)제 등)이나 트리폴리인산 칼륨(태평화학산업(주)제 등)등을 들 수 있다. 그 중에서도 특히 피로인산 나트륨이 바람직하다. 이들의 폴리인산염은, 그 1종을 단독으로 또는 2종 이상을 혼합하여 사용된다.Specific examples of the compound include sodium pyrophosphate having a degree of polymerization (n) = 2 (manufactured by Taiping Chemical Industry Co., Ltd.), potassium pyrophosphate (manufactured by Taiping Chemical Industry Co., Ltd.), and n = 3 sodium tripolyphosphate (central glass ( And the like, and tripolyphosphate potassium (manufactured by Taiping Chemical Industry Co., Ltd.). Especially, sodium pyrophosphate is preferable. These polyphosphates are used individually by 1 type or in mixture of 2 or more types.

수용성 폴리인산염의 배합량은, 조성물 전체의 0.3 내지 1.2%(질량%, 이하 마찬가지)이고, 특히 0.5 내지 1.0%가 바람직하다. 0.3% 미만이면 치면 오염에 대한 부착 억제 효과가 충분히 발휘되지 않고, 1.2%를 초과하면 라우릴황산염과의 병용 배합 조성에서는 구강 점막에 대해 자격이 발생하는 경우가 있다.The compounding quantity of water-soluble polyphosphate is 0.3 to 1.2% (mass% or less) of the whole composition, and 0.5 to 1.0% is especially preferable. If it is less than 0.3%, the adhesion inhibitory effect against tooth contamination is not sufficiently exhibited, and if it exceeds 1.2%, qualification may occur for the oral mucosa in a combination composition with lauryl sulfate.

본 발명의 치약 조성물에 사용하는 (B)성분인 메틸비닐에테르 무수 말레인산 공중합체는, 25℃, pH7.0에서의 2.0% 수용액의 점도가 5 내지 1000mPa·s를 나타내는 것이다. 또한, 2.0% 수용액은, 메틸비닐에테르 무수 말레인산 공중합체와 물을 60 내지 70℃로 가온하면서 교반하여 용해시킨 후, 25℃로 냉각 후, 10N NaOH를 사용하여 pH7.0로 조정하고, 농도가 2.0%가 되도록 증류수를 가한 후, 최종 pH가 7.0이 되도록 제작하였다. 메틸비닐에테르 무수 말레인산 공중합체는, 메틸비닐에테르와 무수 말레인산을 공중합 반응시킨 것이고, 메틸비닐에테르와 무수 말레인산의 배합 비율은, 25℃, pH7.0에서의 2.0% 수용액의 점도가 상기 기재된 점도 내라면 특히 한정되지 않는다.The methylvinyl ether maleic anhydride copolymer of (B) component used for the toothpaste composition of this invention shows the viscosity of 5-1000 mPa * s at 25 degreeC and the pH of 2.0% aqueous solution at pH7.0. In addition, the 2.0% aqueous solution was dissolved while stirring the methylvinyl ether maleic anhydride copolymer and water at 60 to 70 ° C, and then cooled to 25 ° C, adjusted to pH7.0 using 10N NaOH, and the concentration was Distilled water was added to 2.0%, and the final pH was produced to 7.0. The methylvinyl ether maleic anhydride copolymer is obtained by copolymerizing methyl vinyl ether and maleic anhydride, and the mixing ratio of methyl vinyl ether and maleic anhydride is 25% at 25 ° C. and the viscosity of the 2.0% aqueous solution at pH 7.0 is within the viscosity described above. Ramen is not particularly limited.

또한, 25℃, pH7.0에서의 2.0% 수용액의 점도는, 5 내지 1000mPa·s, 바람직하게는 5 내지 500mPa·s이다. 점도가 5mPa·s 미만이면 오염에 대한 부착 억제 효과가 충분히 발휘되지 않고, 1000mPa·s를 초과하면 치약 조성물 사용시에 구강 내에 끈적거림이 생기고, 사용시에 충분한 거품 생김을 얻을 수 없다. 또한, 점도는, (주)도쿄계량기제 B형 점토계(형식 : BL), 로터 No.1 또는 2를 사용, 회전수 30rpm, 측정 시간 3분간, 25℃, pH7.0로 조정한 2.0% 수용액에서의 측정치이다. 또 한, pH 조정에는, pH미터(동아 디케이케이 주식회사제, 형식 : HM-30G) 및 pH전극(동아 디케이케이 주식회사제, 형식 : GST-5721C)를 이용하였다.Moreover, the viscosity of 2.0% aqueous solution in 25 degreeC and pH7.0 is 5-1000 mPa * s, Preferably it is 5-500 mPa * s. If the viscosity is less than 5 mPa · s, the effect of inhibiting adhesion to contamination is not sufficiently exhibited. If the viscosity is more than 1000 mPa · s, stickiness occurs in the oral cavity when the toothpaste composition is used, and sufficient foaming is not obtained at the time of use. In addition, the viscosity was 2.0% adjusted to 25 degreeC, pH7.0 by 30 rpm of rotation speeds, measuring time 3 minutes using Tokyo-BK type B clay meter (model: BL) and rotor No. 1 or 2. It is the measured value in aqueous solution. In addition, a pH meter (made by Dong-A DKK Co., Ltd., model: HM-30G) and a pH electrode (made by Dong-A DKK Co., Ltd., model: GST-5721C) were used for pH adjustment.

이와 같은 공중합체로서는, ISP사제의 간트레츠, 예를 들면, GANTREZ AN-119(25℃, pH7.0에서의 2.0% 수용액의 점도가 10mPa·s), AN-139(25℃, pH7.0에서의 2.0% 수용액의 점도가 60mPa·s), AN-169(25℃, pH7.0에서의 2.0% 수용액의 점도가 450mPa·s) 등이 이용 가능하다.As such a copolymer, Gantretz manufactured by ISP, for example, GANTREZ AN-119 (the viscosity of 2.0% aqueous solution in 25 degreeC, pH7.0 is 10 mPa * s), AN-139 (25 degreeC, pH7.0) The viscosity of the 2.0% aqueous solution at 60 mPa * s), AN-169 (The viscosity of the 2.0% aqueous solution at 25 degreeC, pH7.0 is 450 mPa * s), etc. can be used.

메틸비닐에테르 무수 말레인산 공중합체의 배합량은, 조성물 전체의 0.1 내지 2.0%이고, 특히 0.5 내지 1.0%가 바람직하다. 배합량이 0.1% 미만이면, 치면 오염에 대한 부착 억제 효과가 충분히 발휘되지 않고, 2.0%를 초과하면 사용시의 거품이 잘 일지 않는다.The compounding quantity of the methyl vinyl ether maleic anhydride copolymer is 0.1 to 2.0% of the whole composition, and 0.5 to 1.0% is especially preferable. If the blending amount is less than 0.1%, the effect of inhibiting adhesion to tooth surface contamination is not sufficiently exhibited. If the blending amount is more than 2.0%, foaming at the time of use does not easily occur.

본 발명에 사용하는 (C)성분인 라우릴황산염은, 고급지방산으로 합성된 평균 알킬쇄(鎖) 길이가 12인 음이온성 계면활성제이다. 구체적으로는, 라우릴황산 나트륨, 라우릴황산 칼륨, 라우릴황산 암모늄 등을 들 수 있지만, 치약 조성물에의 배합의 편리성으로부터, 라우릴황산 나트륨(동방화학공업(주)제, 제일제약(주)제 등)이 가장 바람직하다.The lauryl sulfate which is (C) component used for this invention is an anionic surfactant whose average alkyl chain length synthesize | combined with higher fatty acid is 12. Specifically, sodium lauryl sulfate, potassium lauryl sulfate, ammonium lauryl sulfate, etc. are mentioned, but sodium lauryl sulfate (Dong Bang Chemical Co., Ltd. product, Cheil Pharm. Co., Ltd.) from the convenience of mix | blending to a toothpaste composition. And the like) are most preferred.

라우릴황산염의 배합량은, 조성물 전체의 0.6 내지 2.0%이고, 바람직하게는 0.8 내지 1.5%이다. 배합량이 0.6% 미만이면 치면 오염 부착 억제 효과가 발휘되지 않는다. 또한, 2.0%를 초과하면 구강 점막에 대해 자격이 생기는 경우가 있다.The compounding quantity of lauryl sulfate is 0.6 to 2.0% of the whole composition, Preferably it is 0.8 to 1.5%. If the blending amount is less than 0.6%, the effect of suppressing fouling adhesion is not exerted. Moreover, when it exceeds 2.0%, qualification may arise about an oral mucosa.

또한, 본 발명의 치약 조성물은, 거품 생김 성분으로서 (D)성분인 베타인형 양성 계면활성제를 함유한다. 베타인형 양성 계면활성제로서는, 2-알킬-N-카르복시 메틸-N-히드록시에틸이미다졸리늄베타인, 라우릴디메틸아미노아세트산 베타인, 지방산 아미드프로필베타인 등을 들 수 있고, 이들의 1종을 단독으로 또는 2종 이상을 조합시켜서 사용할 수 있다.Moreover, the toothpaste composition of this invention contains the betaine type amphoteric surfactant which is (D) component as a foaming component. Examples of the betaine amphoteric surfactants include 2-alkyl-N-carboxymethyl-N-hydroxyethylimidazolinium betaine, lauryldimethylaminoacetic acid betaine, fatty acid amidepropyl betaine, and the like. A species can be used individually or in combination of 2 or more types.

상기 양성 계면활성제의 알킬쇄 길이로서는, 어느 경우도 거품이 생기는 점에서, 바람직하게는 알킬쇄의 탄소수가 8 내지 20, 보다 바람직하게는 10 내지 18이다. 이들 중에서는, 거품 생김 및 저자격성인 점에서, 2-알킬-N-카르복시메틸-N-히도록시에틸이미다졸리늄베타인이 바람직하다. 2-알킬-N-카르복시메틸-N-히도록시에틸이미다졸리늄베타인으로서는, 상품명 에나지콜 C-4OH로서 라이온(주)에서 판매되고 있는 2-야자유알킬-N-카르복시메틸-N-히도록시에틸이미다졸리늄베타인나트륨 수용액 등이 사용될 수 있다.As an alkyl chain length of the said amphoteric surfactant, since foaming also arises in any case, Preferably it is 8-20 carbon atoms of an alkyl chain, More preferably, it is 10-18. Among them, 2-alkyl-N-carboxymethyl-N-hypoxyethylimidazoliniumbetaine is preferable in terms of foaming and hypoallergenicity. As 2-alkyl-N-carboxymethyl-N-hydroxyethyl imidazolinium betaine, 2-palm oil alkyl-N-carboxymethyl-N-hydroxy sold by Lion Co., Ltd. as a brand name Enazol C-4OH is mentioned. Aqueous sodium imidazolinium betaine solution and the like can be used.

베타인형 양성 계면활성제의 배합량은, 조성물 전체에 대해, 순분(純分) 환산으로서 0.2 내지 1.0%, 바람직하게는 0.3 내지 0.8%이다. 배합량이 0.2% 미만이면 이를 닦을 때에 있어서의 거품 생김이 불충분하다. 또한, 1.0%를 초과하면, 수용성 폴리인산염 및 라우릴황산염과의 병용 배합 조성에서는 구강 점막에 대해 자격이 생긴다. 또한, 베타인형 양성 계면활성제는 물 등과의 혼액으로서 밖에 얻어지지 않는 것이 있는데, 본 발명에서의 배합시의 질량은 용매 등을 제외한 활성제의 순분이다.The compounding quantity of a betaine type amphoteric surfactant is 0.2-1.0% in terms of pure content, Preferably it is 0.3-0.8% with respect to the whole composition. If the amount is less than 0.2%, foaming at the time of wiping the teeth is insufficient. In addition, if it exceeds 1.0%, the combination composition with the water-soluble polyphosphate and lauryl sulfate will qualify for the oral mucosa. In addition, although a betaine type amphoteric surfactant may be obtained only as a mixture with water etc., the mass at the time of mix | blending in this invention is a pure part of active agent except a solvent etc ..

또한, 본 발명에서는, 치면 오염에 대한 부착 억제 효과와 사용시에 충분한 거품 생김을 가지며, 또한 구강 점막에 대해 저자격이기 때문에, 상기 베타인형 양성 계면활성제에 대한 라우릴황산염의 배합량((C)/(D))을 질량비로 1 내지 4, 바람 직하게는 2 내지 3의 범위로 하는 것이 필요하다. (C)/(D)가 1 미만에서는 치면 오염에 대한 부착 억제 효과가 발휘되지 않고, 사용시의 거품 생김이 불충분하게 된다. 4를 초과하면 자격이 생기는 경우가 있다.In addition, in the present invention, the compounding amount of lauryl sulfate to the betaine-type amphoteric surfactant ((C) / It is necessary to make (D)) into the range of 1-4 and preferably 2-3 in mass ratio. If (C) / (D) is less than 1, the adhesion inhibiting effect against contamination is not exhibited, and foaming at the time of use becomes insufficient. If you exceed 4, you may qualify.

본 발명의 치약 조성물은, 크림치약, 액체치약, 윤제치약(潤製齒磨) 등으로서 통상 방법에 의해 조제할 수 있지만, 상기 필수 성분에 더하여, 본 발명의 효과를 손상시키지 않는 범위에서 제형(劑型)에 따른 임의 성분을 배합할 수 있다. 크림치약의 경우라면, 임의 성분으로서, 연마제, 라우릴황산염 및 베타인형 양성 계면활성제 이외의 계면활성제, 점조제, 점결제, 감미제, 방부제, 향료, 각종 유효 성분 등을 배합하고, 물과 혼화하여, 통상 방법에 따라 제조할 수 있다.Although the toothpaste composition of this invention can be prepared by a conventional method as a cream toothpaste, a liquid toothpaste, a lubricant toothpaste, etc., in addition to the said essential component, the formulation (within the range which does not impair the effect of this invention) Arbitrary components according to 劑型 can be blended. In the case of a cream toothpaste, as an optional ingredient, surfactants other than an abrasive, lauryl sulfate, and a betaine type amphoteric surfactant, a viscous agent, a caking additive, a sweetener, a preservative, a fragrance | flavor, various active ingredients, etc. are mix | blended, and it mixes with water, It can manufacture according to a conventional method.

연마제로서는, 제 2 인산 칼슘(2수화물 또는 무수물), 제 1 인산 칼슘, 제 3 인산 칼슘, 피로인산 칼슘, 탄산 칼슘, 수산화 알루미늄, 알루미나, 탄산 마그네슘, 제 3 인산 마그네슘, 불용성 메타인산 나트륨, 불용성 메타인산 칼륨, 산화 티탄, 제올라이트, 무수 규산, 함수(含水) 규산, 규산 티타늄, 규산 지르코니움, 합성수지계 연마제 등을 들 수 있지만, 효과의 면에서 무수 규산 등의 실리카계의 연마제가 바람직하다. 연마제의 배합량은, 대표적인 제형인 크림치약인 경우에는, 조성물 전체의 5 내지 50%가 좋고. 바람직하게는 10 내지 50%가 좋다.Examples of the abrasive include dibasic calcium phosphate (dihydrate or anhydride), dibasic calcium phosphate, tricalcium phosphate, calcium pyrophosphate, calcium carbonate, aluminum hydroxide, alumina, magnesium carbonate, tertiary magnesium phosphate, insoluble sodium metaphosphate, insoluble Potassium metaphosphate, titanium oxide, zeolite, silicic anhydride, hydrous silicic acid, titanium silicate, zirconium silicate, synthetic resin-based abrasives, and the like, but silica-based abrasives such as silicic anhydride are preferred in view of the effect. . In the case of the cream toothpaste which is a typical formulation, the compounding quantity of an abrasive | polishing agent may be 5 to 50% of the whole composition. Preferably 10 to 50% is good.

또한, 계면활성제로서는, 본 발명의 효과를 손상시키지 않는 범위에서, 비이온 계면활성제를 1종 단독으로 또는 2종 이상을 병용하는 것이 가능하다. 비이온 계면활성제로서는, 자당(蔗糖) 지방산 에스테르, 말토스 지방산 에스테르 등의 자당 지방산 에스테르, 말티톨 지방산 에스테르, 락톨방산 에스테르 등의 당알코올 지방산 에스테르, 알킬올마이도, 폴리옥시에틸렌소르비탄모노스티어레이트 등의 폴리옥시에틸렌소르비탄 지방산 에스테르, 폴리옥시에틸렌 경화 피마자유 등의 폴리옥시에틸렌 지방산 에스테르, 라우릴산 모노 또는 디에탄올아미드 등의 지방산 디에탄올아미드, 소르비탄 지방산 에스테르, 폴리옥시에틸렌 고급 알코올 에테르, 폴리옥시에틸렌폴리옥시프로필렌 공중합체, 폴리옥시에틸렌폴리옥시프로필렌 지방산 에스테르, 폴리글리세린 지방산 에스테르 또는 플루로닉 등을 들 수 있다. 비이온 계면활성제의 배합량은, 조성물 전체의 0.1 내지 2%가 알맞다. 또한, 본 발명 조성물에 있어서, 계면활성제의 총 배합량은 0.8 내지 3%의 범위인 것이 바람직하다.Moreover, as surfactant, it is possible to use 1 type individually or in combination of 2 or more types of nonionic surfactant, in the range which does not impair the effect of this invention. Examples of nonionic surfactants include sucrose fatty acid esters such as sucrose fatty acid esters and maltose fatty acid esters, sugar alcohol fatty acid esters such as maltitol fatty acid esters, and lactolic acid esters, alkylol mydoes, and polyoxyethylene sorbitan monostearates. Polyoxyethylene fatty acid esters such as polyoxyethylene sorbitan fatty acid esters, polyoxyethylene hardened castor oil, fatty acid diethanolamides such as lauryl acid mono or diethanolamide, sorbitan fatty acid esters, polyoxyethylene higher alcohol ethers , Polyoxyethylene polyoxypropylene copolymer, polyoxyethylene polyoxypropylene fatty acid ester, polyglycerol fatty acid ester, pluronic and the like. As for the compounding quantity of a nonionic surfactant, 0.1-2% of the whole composition is suitable. Moreover, in the composition of the present invention, the total amount of the surfactant is preferably in the range of 0.8 to 3%.

점조제로서는, 소르비트, 글리세린, 프로필렌글리콜, 폴리에틸렌글리콜, 크실리톨, 말티톨, 락톨로부터 선택되는, 적어도 1종 이상에 더하여, 적절히, 1,3-부틸렌글리콜, 폴리프로필렌글리콜, 에탄올, 변성 에탄올, 당알코올 환원전분 당화물 등을 사용할 수 있다. 그 배합량은, 본 발명의 구강용 조성물의 형태, 사용 목적 등에 따라 적절히 선택된다(통상 배합량은 조성물 전체의 10 내지 50%).As the viscous agent, in addition to at least one or more selected from sorbet, glycerin, propylene glycol, polyethylene glycol, xylitol, maltitol and lactol, 1,3-butylene glycol, polypropylene glycol, ethanol, modified ethanol as appropriate , Sugar alcohol reduced starch saccharose and the like can be used. The compounding quantity is suitably selected according to the form, purpose of use, etc. of the composition for oral cavity of this invention (normally, compounding quantity is 10 to 50% of the whole composition).

증점제로서는, 카라기난, 카르복시메틸셀룰로오스나트륨, 메틸셀룰로오스, 히도록시에틸셀룰로오스나트륨, 알긴산 나트륨, 크산탄검, 트라칸트검, 카라야검, 아라비아검, 로커스트빔검, 폴리비닐알코올, 폴리아크릴산 나트륨, 카르복시비닐 폴리머, 폴리비닐피롤리돈, 카르보폴, 실리카겔, 알루미늄실리카겔, 비검(bee gum), 라포나이트 등을 들 수 있다(통상 배합량은 조성물 전체의 0.1 내지 5%).Examples of the thickener include carrageenan, sodium carboxymethyl cellulose, methyl cellulose, sodium hydroxyethyl cellulose, sodium alginate, xanthan gum, tracant gum, karaya gum, gum arabic, locust beam gum, polyvinyl alcohol, sodium polyacrylate, and carboxyvinyl polymer. , Polyvinylpyrrolidone, carbopol, silica gel, aluminum silica gel, bee gum, laponite and the like (usually 0.1 to 5% of the total composition).

감미제로서는, 사카린나트륨, 스테비오사이드, 스테비아 엑기스, 파라메톡시신나믹알데히도, 네오헤스피리딘 디히드로칼콘, 페릴라루틴, 글리시르리진, 타우마 틴, 아스파라틸페닐알라닌메틸에스텔 등을 들 수 있다.Examples of sweetening agents include sodium saccharin, stevioside, stevia extract, paramethoxycinnamicaldehyde, neohespyridine dihydrochalcone, perillarutin, glycyrazine, taumatin, aspartylphenylalanine methyl ester, and the like. .

향료로서는, 멘톨, 아네톨, 카르본, 유젠올, 리모넨, n-데실알코올, 시트로넬롤, α-테르피네올, 시트로넬릴아세테이트, 시네올, 린나롤, 에틸리나롤, 바닐린, 티몰, 스페아민트유, 페퍼민트유, 레몬유, 오렌지유, 세이지유, 로즈마리유, 계피유, 피멘토유, 계엽유(桂葉油), 자소유(紫蘇油), 동녹유(冬綠油), 정자유(丁字油) 또는 유칼리유 등을 들 수 있다(통상 배합량은 0.00001 내지 1%).As the fragrance, menthol, anetol, carbon, eugenol, limonene, n-decyl alcohol, citronellol, α-terpineol, citronellyl acetate, cineol, rinnarol, ethylinalol, vanillin, thymol, Spearmint oil, peppermint oil, lemon oil, orange oil, sage oil, rosemary oil, cinnamon oil, pimento oil, cinnamon oil, purple soybean oil, copper green oil, sperm oil (Iii) or eucalyptus oil (usually 0.00001 to 1%).

본 발명의 조성물에는, 이들의 성분 이외에도 약효 성분 또는 유효 성분으로서, 덱스트라나제, 아밀라제, 푸로테이나제, 무타나제 등의 효소, 모노플루오로인산 나트륨 등의 알칼리 금속 모노훌오로포스페이트, 불화 나트륨, 불화 제 1 주석 등의 불화물, 트라넥삼산, 입실론아미노카프론산, 알루미니움크로르히드록시알란토인, 아줄렌, 글리시르리진산염, 글리시르레틴산, 염화 나트륨, 비타민류 등의 항염증제, 구리 클로로필, 글루콘산 구리, 세틸피리듐클로라이드, 염화 벤잘코늄, 트리클로산, 히노키티올, 염화 리소짐 등의 살균제, 폴리인산염류, 제올라이트 등의 치석 예방제 등도 배합할 수 있다. 또한, 상기 약효 성분 또는 유효 성분의 배합량은, 유효량으로 할 수 있다.In the composition of the present invention, in addition to these components, as an active ingredient or an active ingredient, enzymes such as dextranase, amylase, furotenase and mutanase, alkali metal monohulophosphates such as sodium monofluorophosphate and fluoride Anti-inflammatory agents such as fluorides such as sodium and fluorinated tin, trinexamic acid, epsilonaminocaproic acid, aluminium chlorhydroxyalantoin, azulene, glycyrrhizinate, glycyrrhetinic acid, sodium chloride, and vitamins; Disinfectants, such as copper chlorophyll, copper gluconate, cetylpyridium chloride, benzalkonium chloride, triclosan, hinokthiol, and lysozyme, polyphosphates, and tartar preventive agents, such as a zeolite, can also be mix | blended. In addition, the compounding quantity of the said active ingredient or an active ingredient can be made into an effective amount.

본 발명의 치약 조성물의 pH는 6 내지 9가 알맞다. pH가 6 미만이면, 치약 사용시에 치아 에나멜질이 손상하는 경우가 있다. 또한, pH가 9를 초과하면, 치면 오염에 대한 부착 억제 효과가 발휘되지 않는 경우가 있다. 또한, pH 조정형으로서는, 통상, 수산화나트륨, 인산 수소 2나트륨 등을 들 수 있다.The pH of the toothpaste composition of this invention is 6-9 suitably. When pH is less than 6, tooth enamel may be damaged at the time of using toothpaste. Moreover, when pH exceeds 9, the adhesion inhibitory effect to tooth surface contamination may not be exhibited. Moreover, as a pH adjustment type, sodium hydroxide, sodium hydrogen phosphate, etc. are mentioned normally.

본 발명의 치약 조성물을 수용하는 용기의 재질은 특히 제한되지 않고, 통상 치약 조성물에 사용되는 용기를 사용할 수 있다. 구체적으로는, 폴리에틸렌, 폴리프로필렌, 폴리에틸렌테레프탈레이트, 나일론 등의 플라스틱 용기 등을 사용할 수 있다.The material of the container containing the toothpaste composition of this invention is not specifically limited, Usually, the container used for a toothpaste composition can be used. Specifically, plastic containers such as polyethylene, polypropylene, polyethylene terephthalate, and nylon can be used.

실시예Example

이하, 실시예 및 비교예를 나타내어 본 발명을 구체적으로 설명하지만, 본 발명은 하기 실시예로 제한된 것이 아니다. 또한, 이하의 예에서 배합량은 모두 질량%이다.Hereinafter, although an Example and a comparative example are shown and this invention is demonstrated concretely, this invention is not limited to the following Example. In addition, in the following example, all compounding quantities are the mass%.

[실시예 1 내지 9, 비교예 1 내지 9][Examples 1 to 9 and Comparative Examples 1 to 9]

표 1, 2에 표시하는 조성의 치약 조성물을 하기 제조법에 의해 조제하였다.Toothpaste compositions of the compositions shown in Tables 1 and 2 were prepared by the following production method.

치약 조성물의 제조법 :Recipe for toothpaste composition:

(1) 정제수중에 수용(水溶) 성분(점결제, 프로필렌글리콜 등을 제외한다)을 상온에서 혼합 용해시킨 A상(相)을 조제하였다.(1) The A phase which mixed-dissolved the water component (except a binder, propylene glycol, etc.) in purified water at normal temperature was prepared.

(2) 프로필렌글리콜중 점결제를 상온에서 분산시킨 B상을 조제하였다.(2) The B phase which disperse | distributed the binder in propylene glycol at normal temperature was prepared.

교반중의 A상중에 B상을 첨가 혼합하고, C상을 조제하였다.The B phase was added and mixed in the A phase under stirring, and the C phase was prepared.

(3) C상중에, 향료, 연마제, 계면활성제 등의 수용성 성분 이외의 성분을, 1.5ℓ 니더(이시야마공작소제)를 이용하여 상온에서 혼합하고, 감압에 의한 탈포를 행하고, 치약 조성물 1.2㎏을 얻었다.(3) In phase C, components other than water-soluble components such as perfumes, abrasives, and surfactants are mixed at room temperature using 1.5 L kneader (manufactured by Ishiyama Corporation), degassed under reduced pressure, and 1.2 kg of toothpaste composition is prepared. Got.

얻어진 시험 치약제를 사용하여, 치면 오염 부착 억제 효과, 구강 점막에 대한 자격성, 이 닦을 때의 거품 생김을 이하의 방법에 의해 평가하였다. 또한, 치면 오염 부착 억제 효과의 평가는, 대표적인 치면 오염인 타닌철(鐵) 스테인 부착 억 제 평가를 행하였다.Using the obtained test toothpaste, the tooth surface contamination inhibitory effect, the qualification with respect to the oral mucosa, and the foaming at the time of wiping were evaluated by the following method. In addition, evaluation of the tooth surface contamination adhesion inhibitory effect evaluated the inhibition of tannin iron adhesion which is a typical tooth surface contamination.

타닌철 스테인 부착 억제 평가의 시험 방법 :Test Method of Tannin Iron Stain Adhesion Inhibition Evaluation:

하이드록시 아바타이트 펠릿 표면(펜탁스사제, 직경 7㎜×두께 3.5㎜)을 샌드블라스트에 처리 후, 중성세제 수용액중, 초음파 세정기로 세정하였다. 30% 인산 수용액에 표면을 에칭(10 분간), 수세하고, 자연 건조 후, 분광식 색차계(일본전기색공업주식회사제, 형식 : SE-2000)를 이용하여 타닌철 스테인 부착 전의 펠릿의 Lab값을 측정하고, L값을 L0로 하였다. 또한, 조제한 치약제를 2배량의 이온교환수로 희석한 치약 분산액을 제작하였다. 상기한 펠릿에 대해, 치약 분산액→ 0.5질량% 알부민 수용액→ 타닌 추출액→ 0.6질량% 구연산철(Ⅲ)암모늄 수용액으로 1시간씩 반복 침지하는 조작을 50회 반복하고, 상온에서 1일 바람에 건조시킨(風乾) 후, 흐르는 물(流水)로 세정하고, 재차 바람에 건조시켜 착색 펠릿을 제작하였다. 타닌 추출액은, 비등시킨 이온교환수 1200㎖중 , 일본차(日本茶)(명칭 : 노송) 50g, 홍차(립톤제 브리스크 디벅) 5봉지, 인스턴트 커피(네스카페제) 12g을 넣고 하룻밤 방치하고, 일본차 및 홍차를 여과하여 제거하여 제작하였다. 제작한 착색 펠릿의 Lab값을 측정하고, L값을 L1으로 하였다. 또한, 치약 분산액 대신에 이온교환수 처리를 한 펠릿의 L값(L2)을 대조(對照)로 하여, 다음 식에 의해 착색 오염 부착 억제율을 산출하고, 착색 오염 부착 억제 효과를 산출하였다.The surface of the hydroxy avatarite pellets (manufactured by Pentax, 7 mm in diameter x 3.5 mm in thickness) was subjected to sandblasting, and then washed with an ultrasonic cleaner in an aqueous neutral detergent solution. Lab value of pellets before etching tannin iron by using a spectrophotometer (Japan Electro-Color Industry Co., Ltd., Model: SE-2000) after etching (water for 10 minutes), washing the surface with 30% phosphoric acid aqueous solution. Was measured and L value was made into L0. In addition, a toothpaste dispersion prepared by diluting the prepared toothpaste with twice the amount of ion-exchanged water was prepared. To the pellets described above, the procedure of repeated immersion in a toothpaste dispersion → 0.5 mass% albumin aqueous solution → tannin extract → 0.6 mass% ferric citrate (III) ammonium aqueous solution for 1 hour was repeated 50 times, and dried at room temperature for 1 day. After wind, it wash | cleaned with running water, and it dried again by the wind, and produced the colored pellet. The tannin extract was placed in 1200 ml of boiled ion-exchanged water, 50 g of Japanese tea (name: Noson), 5 bags of black tea (Brisk Dibuck) and 12 g of instant coffee (Nescafe), and left overnight. Japanese tea and black tea were produced by filtration. The Lab value of the produced colored pellets was measured and L value was made into L1. In addition, the L value (L2) of the pellets which were treated with ion-exchanged water instead of the toothpaste dispersion was used as a control, and the inhibition of coloring contamination adhesion was calculated by the following equation, and the coloring contamination adhesion inhibition effect was calculated.

착색 오염 부착 억제율(%)=[(L1-L2)/(L0-L2)]×100Color contamination adhesion inhibition rate (%) = [(L1-L2) / (L0-L2)] × 100

얻어진 착색 오염 부착 억제율로부터, 이하의 기준에 따라 담뱃진 제거 효과를 평가하였다,From the obtained stain stain adhesion inhibition, the cigarette removal effect was evaluated according to the following criteria,

평가 기준Evaluation standard

◎ : 착색 오염 부착 억제율 60% 이상◎: 60% or more suppression of coloring contamination adhesion

○ : 착색 오염 부착 억제율 50% 이상 60% 미만(Circle): 50% or more of coloring stain adhesion inhibition less than 60%

△ : 착색 오염 부착 억제율 40% 이상 50% 미만(Triangle | delta): 40% or more of coloring contamination adhesion suppression rate is less than 50%

× : 착색 오염 부착 억제율 40% 미만X: Less than 40% of colored contamination adhesion inhibition

구강 점막에 대한 자격성의 평가 방법 :Method of evaluation of eligibility for oral mucosa:

점막 자격에 민감한 피험자 10명을 이용하여, 표 1, 2에 도시하는 각 조성의 치약 조성물 약 1g을 칫솔에 취하고, 3분간 이 닦기를 행하였을 때의 구강 점막에 대한 자격의 정도를, 「자격을 강하게 느낀다」를 1점, 「자격을 느낀다」를 2점, 「자격을 거의 느끼지 않는다」를 3점, 「자격을 느끼지 않는다」를 4점으로 하여, 10명의 평균점으로부터 이하의 기준으로 구강 점막에 대한 자격성을 평가하였다.Using 10 subjects sensitive to mucosa qualification, about 1 g of toothpaste composition of each composition shown in Table 1, 2 was taken in a toothbrush, and the grade of the qualification with respect to the oral mucosa when this brush was performed for 3 minutes was "qualified." We make "we feel strong" one point, "we feel qualification" two points, "we rarely feel qualification" three points, "we do not feel qualification" four points, and oral mucosa from the mean of ten people by the following standards The eligibility for was evaluated.

평가 기준 ;Evaluation standard ;

◎ : 평균점 3.5점 이상 4.0점 이하◎: 3.5 points or more and 4.0 points or less

○ : 평균점 3.0점 이상 3.5점 미만(Circle): Average score 3.0 points or more and less than 3.5 points

△ : 평균점 2.0점 이상 3.0점 미만Δ: 2.0 points or more and less than 3.0 points

× :, 평균점 1.0점 이상 2.0점 미만X: Average point 1.0 or more and less than 2.0 points

이 닦을 때의 거품 생김 평가 방법 :How to evaluate foaming when brushing:

피험자 10명을 이용하여, 표 1, 2에 표시하는 각 조성의 치약 약 1g을 칫솔에 취하고, 3분간 이 닦기를 행하였을 때의 거품 생김을, 「거품 생김 매우 좋다」, 「거품 생김 좋다」, 「거품 생김 약간 적다」, 「거품 생김 적다」의 4단계로 회답을 얻었다. 이 회답중, 「거품 생김 매우 좋다」를 4점, 「거품 생김 좋다」를 3점, 「거품 생김 약간 적다」를 2점, 「거품 생김 적다」를 1점으로 하여, 10명의 평균점으로부터 이하의 기준으로 사용감을 평가하였다.Using 10 subjects, about 1 g of toothpaste of each composition shown in Tables 1 and 2 was put in a toothbrush, and foaming when this wiping was performed for 3 minutes was "foam good" and "good foaming". We got answer in four steps of "a little bubble", "a little bubble". In this answer, we make three points of "bubble goodness" three points, "bubble goodness little" two points, "bubble little thing" with one point of "bubble goodness" one point, and from the average point of ten people The feeling of use was evaluated as a standard.

◎ : 평균점 3.5점 이상 4.0점 이하◎: 3.5 points or more and 4.0 points or less

○ : 평균점 3.0점 이상 3.5점 미만(Circle): Average score 3.0 points or more and less than 3.5 points

△ : 평균점 2.0점 이상 3.0점 미만Δ: 2.0 points or more and less than 3.0 points

× : 평균점 1.0점 이상 2.0점 미만×: 1.0 or more average points and less than 2.0 points

[표 1][Table 1]

Figure 112008014233555-pct00001
Figure 112008014233555-pct00001

*1 : 30% 물품을 사용하고, 표중의 값은 순분 환산한 배합량을 나타내었다.* 1: The 30% article was used and the value in the table | surface showed the compounding quantity converted into the net fraction.

*2 : (D)성분은 순분 환산하고, 그 값을 이용하여 (C)/(D)의 비율을 구하였다.* 2: The component (D) was purely converted and the ratio of (C) / (D) was calculated using the value.

[표 2][Table 2]

Figure 112008014233555-pct00002
Figure 112008014233555-pct00002

*1 : 30% 물품을 사용하고, 표중의 값은 순분 환산한 배합량을 나타내었다.* 1: The 30% article was used and the value in the table | surface showed the compounding quantity converted into the net fraction.

*2 : (D)성분은 순분 환산하고, 그 값을 이용하여 (C)/(D)의 비율을 구하였다.* 2: The component (D) was purely converted and the ratio of (C) / (D) was calculated using the value.

피로인산 4나트륨 : 태평화학사제Tetrasodium pyrophosphate: manufactured by Taepyung Chemical Co., Ltd.

트리폴리인산 나트륨 : 센트럴유리(주)제Sodium tripolyphosphate: Central Glass Co., Ltd.

메틸비닐에테르 무수 말레인산 공중합체 : ISP사제(상품명 : 간토레츠 AN-169)Methyl vinyl ether maleic anhydride copolymer: manufactured by ISP (trade name: Kantoretsu AN-169)

라우릴황산 나트륨 : 동방화학사제Sodium lauryl sulfate: Toyo Chemical Co., Ltd.

2-야자유알킬-N-카르복시메틸-N-히도록시에틸이미다졸리늄베타인나트륨(30% 수용액)): 라이온사제(상품명 : 에나지콜 C-4OH)2-palm oil alkyl-N-carboxymethyl-N-hydroxyethylimidazolinium beta sodium (30% aqueous solution): Lion company make (brand name: enazicol C-4OH)

표 1, 2로부터, 본 발명의 (A) 내지 (D)성분을 특정량 함유하며, 또한 (C)/(D)의 질량비가 1 내지 4인 치약 조성물(실시예 1 내지 9)은, 치면 오염 부착 억제 효과, 구강 점막에 대한 자격성, 이 닦을 때의 거품 생김이 모두 양호하였다. 한편, 본 발명의 필수 요건의 어느 하나를 결여한 치약 조성물(비교예 1 내지 9)은, 치면 오염 부착 억제 효과, 구강 점막에 대한 자격성, 이 닦을 때의 거품 생김중 어느 하나의 점에서 충분한 효과가 발휘되지 않았다.From Table 1, 2, the toothpaste composition (Examples 1-9) which contains the specific amount of (A)-(D) component of this invention, and whose mass ratio of (C) / (D) is 1-4 is the tooth surface Inhibition of fouling adhesion, qualification for oral mucosa, and foaming when brushing were all good. On the other hand, the toothpaste composition (Comparative Examples 1 to 9) lacking any one of the essential requirements of the present invention is sufficient in any one of the effect of inhibiting tooth surface contamination adhesion, qualification for oral mucosa, and foaming when brushing. The effect was not exerted.

[실시예 10] 크림치약Example 10 Cream Toothpaste

(A)피로인산 4나트륨 1.2%(A) 1.2% sodium pyrophosphate

(B)간토레츠 AN-169 1.0(B) Kantoretsu AN-169 1.0

(C)라우릴황산 나트륨 1.2(C) sodium lauryl sulfate 1.2

(D)2-야자유알킬-N-카르복시메틸-N-히도록시에틸이미다졸리늄베타인나트륨(*1) 0.6(D) 2- Palm oil alkyl-N-carboxymethyl-N-hydroxyethylimidazoliniumbetaine sodium (* 1) 0.6

무수 규산 25.0Silicic anhydride 25.0

70% 소르비트액 20.070% Sorbit Liquid 20.0

프로필렌글리콜 3.0Propylene Glycol 3.0

카르복시메틸술룰로오스나트륨 1.4Carboxymethyl cellulose sodium 1.4

사카린나트륨 0.1Saccharin Sodium 0.1

글리시르진산 칼륨 1.0Potassium Glyciric Acid 1.0

토라넥삼산 0.05Toraneksamsan 0.05

α-알루미나 무수물 3.0α-alumina anhydride 3.0

메틸파라벤 0.05Methylparaben 0.05

염화 벤제토늄움 0.25Benzetonium Chloride 0.25

향료 1.0Spices 1.0

인산 수소 2나트륨 1.0Dihydrogen Phosphate 1.0

water 잔부Remainder

계 100.0%Total 100.0%

*1 : 30% 물품을 사용하고, 순분 환산한 배합량을 나타내었다.* 1: The 30% article was used and the compounding quantity converted into pure parts was shown.

(C)/(D)=2(C) / (D) = 2

타닌철 스테인 부착 억제 효과 : ◎Tannin iron stain suppression effect: ◎

구강 점막에 대한 자격성 : ○Qualifications for the oral mucosa: ○

사용시의 거품 생김 평가 : ○Foaming during use Evaluation: ○

상기한 치약 조성물은, 대표적인 치면 오염인 타닌철 스테인에 대한 부착 억제 효과를 가지며, 구강 점막에 대해 저자격이며, 사용시의 거품 생김이 높은 것을 확인하였다..It was confirmed that the above toothpaste composition has an anti-adhesion effect on tannin iron stain, which is a representative tooth surface contamination, is hypoallergenic to the oral mucosa, and foaming during use is high.

[실시예 11] 크림치약Example 11 Cream Toothpaste

(A)피로인산 2나트륨 2칼륨 1.0%(A) disodium pyrophosphate dipotassium 1.0%

(B)간토레츠 AN-139 1.0(B) Kantoretsu AN-139 1.0

(C)라우릴황산 나트륨 1.2(C) sodium lauryl sulfate 1.2

(D)2-야자유알킬-N-카르복시메틸-N-히도록시에틸이미다졸리늄베타인나트륨(*1) 0.4(D) 2- Palm oil alkyl-N-carboxymethyl-N-hydroxyethylimidazoliniumbetaine sodium (* 1) 0.4

수산화 알루미늄 35.0Aluminum Hydroxide 35.0

산화 티탄 2.0Titanium Oxide 2.0

85% 글리세린 20.085% Glycerin 20.0

히도록시에틸셀룰로오스나트륨 1.4Higeshiethyl cellulose sodium 1.4

프로필렌글리콜 3.0.Propylene Glycol 3.0.

사카린나트륨 0.1Saccharin Sodium 0.1

콜로이드상 실리카 3.0Colloidal Silica 3.0

불화 나트륨 0.22Sodium Fluoride 0.22

트릭로산 0.1Trilosan 0.1

메틸파라벤 0.05Methylparaben 0.05

향료 1.0Spices 1.0

water 잔부Remainder

계 100.0%Total 100.0%

*1 : 30% 물품을 사용하고, 순분 환산한 배합량을 나타내었다.* 1: The 30% article was used and the compounding quantity converted into pure parts was shown.

(C)/(D)=3(C) / (D) = 3

타닌철 스테인 부착 억제 효과 : ○Tannin iron stain suppression effect: ○

구강 점막에 대한 자격성 : ◎Qualifications for the oral mucosa: ◎

사용시의 거품 생김 평가 : ○Foaming during use Evaluation: ○

상기한 치약 조성물은, 대표적인 치면 오염인 타닌철 스테인에 대한 부착 억제 효과를 가지며, 구강 점막에 대해 저자격이며, 사용시의 거품 생김도 높은 것을 확인하였다.It was confirmed that the above toothpaste composition had an anti-adhesion effect on tannin iron stain, which is a representative tooth surface contamination, is hypoallergenic to the oral mucosa, and foaming during use was also high.

[실시예 12] 크림치약Example 12 Cream Toothpaste

(A)피로인산 4나트륨 0.8%(A) pyrophosphate tetrasodium 0.8%

(B)간토레츠 AN-119 1.0(B) Kantoretsu AN-119 1.0

(C)라우릴황산 나트륨 0.9(C) sodium lauryl sulfate 0.9

(D)2-야자유알킬-N-카르복시메틸-N-히도록시에틸이미다졸리늄베타인나트륨(*1) 0.3(D) 2- palm oil alkyl-N-carboxymethyl-N-hydroxyethylimidazoliniumbetaine sodium (* 1) 0.3

무수 규산 30.0Silicic anhydride 30.0

70% 소르비트액 20.070% Sorbit Liquid 20.0

85% 글리세린 10.085% Glycerin 10.0

폴리아크릴산 나트륨 1.5Sodium Polyacrylate 1.5

프로필렌글리콜 3.0Propylene Glycol 3.0

사카린나트륨 0.2 Saccharin Sodium 0.2

안식향산 나트륨 0.3Sodium benzoate 0.3

파라옥시안식향산 메틸 0.1Methyl paraoxybenzoate 0.1

모노플루오로인산 나트륨 0.76Sodium Monofluorophosphate 0.76

아세트산 토코페롤 0.1 Tocopherol Acetate 0.1

향료 1.0Spices 1.0

water 잔부Remainder

계 100.0%Total 100.0%

*1 : 30% 물품을 사용하고, 순분 환산한 배합량을 나타내었다.* 1: The 30% article was used and the compounding quantity converted into pure parts was shown.

(C)/(D)=3(C) / (D) = 3

타닌철 부착 억제 효과 : ○Tannin iron adhesion inhibitory effect: ○

구강 점막에 대한 자격성 : ◎Qualifications for the oral mucosa: ◎

사용시의 거품 생김 평가 : ○Foaming during use Evaluation: ○

상기한 치약 조성물은, 대표적인 치면 오염인 타닌철 스테인에 대한 부착 억제 효과를 가지며, 구강 점막에 대해 저자격이며, 사용시의 거품 생김이 높은 것을 확인하였다.The dentifrice composition described above has an anti-adhesion effect on tannin iron stain, which is a representative tooth surface contamination, is hypoallergenic to the oral mucosa, and it is confirmed that foaming at the time of use is high.

[실시예 13] 액상 치약Example 13 Liquid Toothpaste

(A)피로인산 4나트륨 1.0%(A) 1.0% sodium pyrophosphate

(B)간토레츠 AN-139 2.0(B) Kantoretsu AN-139 2.0

(C)라우릴황산 나트륨 1.0(C) sodium lauryl sulfate 1.0

(D)야자유 지방산 아미드프로필베타인(*1) 0.4(D) Palm oil fatty acid amide propyl betaine (* 1) 0.4

무수 규산 15.0Silicic anhydride 15.0

60% 소르비트액 30.060% Sorbit Liquid 30.0

85% 글리세린 35.085% Glycerin 35.0

크산탄검 0.2Xanthan Gum 0.2

카리기난 0.5Carrageenan 0.5

알긴산 나트륨 1.0Sodium Alginate 1.0

프로필렌글리콜 2.0.Propylene Glycol 2.0.

모노플루오로인산 나트륨 0.76Sodium Monofluorophosphate 0.76

덱스트라나제(100만u/g) 0.5Dextranase (1 million u / g) 0.5

사카린나트륨 0.1Saccharin Sodium 0.1

향료 1.0Spices 1.0

water 잔부Remainder

계 100.0%Total 100.0%

*1 : 30% 물품을 사용하고, 순분 환산한 배합량을 나타내었다.* 1: The 30% article was used and the compounding quantity converted into pure parts was shown.

(C)/(D)=2.5(C) / (D) = 2.5

타닌철 스테인 부착 억제 효과 : ◎Tannin iron stain suppression effect: ◎

구강 점막에 대한 자격성 : ◎Qualifications for the oral mucosa: ◎

사용시의 거품 생김 평가 : ○Foaming during use Evaluation: ○

상기한 치약 조성물은, 대표적인 치면 오염인 타닌철 스테인에 대한 부착 억제 효과를 가지며, 구강 점막에 대해 저자격이며, 사용시의 거품 생김도 높은 것을 확인하였다.It was confirmed that the above toothpaste composition had an anti-adhesion effect on tannin iron stain, which is a representative tooth surface contamination, is hypoallergenic to the oral mucosa, and foaming during use was also high.

[실시예 14] 크림치약Example 14 Cream Toothpaste

(A)피로인산 4나트륨 1.0%(A) 1.0% sodium pyrophosphate

(B)간토레츠 AN-169 1.2(B) Kantoretsu AN-169 1.2

(C)라우릴황산 나트륨 1.0(C) sodium lauryl sulfate 1.0

(D)2-야자유알킬-N-카르복시메틸-N-히도록시에틸이미다졸리늄베타인나트륨(*1) 0.5(D) 2- Palm oil alkyl-N-carboxymethyl-N-hydroxyethylimidazoliniumbetaine sodium (* 1) 0.5

카르복시메틸셀룰로오스 나트륨 1.2Carboxymethylcellulose Sodium 1.2

70% 소르비트액 30.070% Sorbet 30.0

무수 규산 25.0Silicic anhydride 25.0

프로필렌글리콜 2.5Propylene Glycol 2.5

불화 나트륨 0.21Sodium Fluoride 0.21

청색 1호 0.0001Blue No. 1 0.0001

향료 1.3Spices 1.3

산화 알루미늄 2.0Aluminum oxide 2.0

4A형 제올라이트 1.54A zeolite 1.5

사카린나트륨 0.2Saccharin Sodium 0.2

산화 티탄 0.2Titanium Oxide 0.2

water 잔부Remainder

계 100.0%Total 100.0%

*1 : 30% 물품을 사용하고, 순분 환산한 배합량을 나타내었다.* 1: The 30% article was used and the compounding quantity converted into pure parts was shown.

(C)/(D)=2(C) / (D) = 2

타닌철 스테인 부착 억제 효과 : ◎Tannin iron stain suppression effect: ◎

구강 점막에 대한 자격성 : ◎Qualifications for the oral mucosa: ◎

사용시의 거품 생김 평가 : ◎Foaming rating when using: ◎

상기한 치약 조성물은, 대표적인 치면 오염인 타닌철 스테인에 대한 부착 억제 효과를 가지며, 구강 점막에 대해 저자격이며, 사용시의 거품 생김도 높은 것을 확인하였다.It was confirmed that the above toothpaste composition had an anti-adhesion effect on tannin iron stain, which is a representative tooth surface contamination, is hypoallergenic to the oral mucosa, and foaming during use was also high.

[실시예 15] 크림치약Example 15 Cream Toothpaste

(A)피로인산 4나트륨 0.3%(A) tetrasodium tetraphosphate 0.3%

(B)간토레츠 AN-169 1.5(B) Kantoretsu AN-169 1.5

(C)라우릴황산 나트륨 1.2(C) sodium lauryl sulfate 1.2

(D)2-야자유알킬-N-카르복시메틸-N-히도록시에틸이미다졸리늄베타인나트륨(*1) 0.4(D) 2- Palm oil alkyl-N-carboxymethyl-N-hydroxyethylimidazoliniumbetaine sodium (* 1) 0.4

무수 규산 25.0Silicic anhydride 25.0

70% 소르비트액 30.070% Sorbet 30.0

카르복시메틸셀룰로오스나트륨 1.2Carboxymethylcellulose Sodium 1.2

프로필렌글리콜 2.0Propylene Glycol 2.0

사카린나트륨 0.2Saccharin Sodium 0.2

안식향산 나트륨 0.3Sodium benzoate 0.3

파라옥시안식향산 메틸 0.1Methyl paraoxybenzoate 0.1

모노플루오로인산 나트륨 0.76Sodium Monofluorophosphate 0.76

아세트산 토코페롤 0.1Tocopherol Acetate 0.1

향료 1.0Spices 1.0

water 잔부Remainder

계 100.0%Total 100.0%

*1 : 30% 물품을 사용하고, 순분 환산한 배합량을 나타내었다.* 1: The 30% article was used and the compounding quantity converted into pure parts was shown.

(C)/(D)=3(C) / (D) = 3

타닌철 부착 억제 효과 : ○Tannin iron adhesion inhibitory effect: ○

구강 점막에 대한 자격성 : ◎Qualifications for the oral mucosa: ◎

사용시의 거품 생김 평가 : ◎Foaming rating when using: ◎

상기한 치약 조성물은, 대표적인 치면 오염인 타닌철 스테인에 대한 부착 억제 효과를 가지며, 구강 점막에 대해 저자격이며, 사용시의 거품 생김도 높은 것을 확인하였다.It was confirmed that the above toothpaste composition had an anti-adhesion effect on tannin iron stain, which is a representative tooth surface contamination, is hypoallergenic to the oral mucosa, and foaming during use was also high.

Claims (2)

(A) 일반식 Mn+2PnO3n+1(단, 식중, M은 Na 또는 K를 나타내고, n은 2 또는 3의 정수이다)로 표시되는 직쇄상의 수용성 폴리인산염의 적어도 1종을 0.3 내지 1.2질량%, (B) 25℃, pH7.0에서의 2.0질량% 수용액의 점도가 5 내지 1000mPa·s인 메틸비닐에테르 무수 말레인산 공중합체를 0.1 내지 2.0질량%, (C) 라우릴황산염을 0.6 내지 2.0질량%, (D) 2-알킬-N-카르복시메틸-N-히도록시에틸이미다졸리늄베타인 0.2 내지 1.0질량%를 함유하고, 또한 (C)/(D)의 배합 비율이 질량비로 1 내지 4인 것을 특징으로 하는 치약 조성물.(A) the general formula M n + 2 P n O 3n + 1, at least one of a water soluble polyphosphate of a straight chain represented by the following (note that the formula, M represents Na or K, n is an integer of 2 or 3) species 0.3-1.2 mass%, (B) 0.1-2.0 mass% of the methylvinyl ether maleic anhydride copolymer whose viscosity of 2.0 mass% aqueous solution in 25 degreeC and pH7.0 is 5-1000 mPa * s, and (C) lauryl 0.6-2.0 mass% of sulfates, 0.2-1.0 mass% of (D) 2-alkyl-N-carboxymethyl-N-hydroxyethyl imidazolinium betaine, and also the combination of (C) / (D) Toothpaste composition, characterized in that the ratio is 1 to 4 by mass. 제 1항에 있어서,The method of claim 1, 또한, 제 2 인산 칼슘2수화물, 제 2 인산칼슘무수물, 제 1 인산 칼슘, 제 3 인산 칼슘, 피로인산 칼슘, 탄산 칼슘, 수산화 알루미늄, 알루미나, 탄산 마그네슘, 제 3 인산 마그네슘, 불용성 메타인산 나트륨, 불용성 메타인산 칼륨, 산화 티탄, 제올라이트, 무수 규산, 함수 규산, 규산 티타늄, 규산 지르코니움, 및 합성수지계 연마제로부터 선택되는 연마제를 5 내지 50질량%, 소르비트, 글리세린, 프로필렌글리콜, 폴리에틸렌글리콜, 크실리톨, 말티톨, 락톨, 1,3-부틸렌글리콜, 폴리프로필렌글리콜, 에탄올, 변성 에탄올, 당알코올 환원전분 당화물로부터 선택되는 점조제를 10 내지 50질량%, 및 카라기난, 카르복시메틸셀룰로오스나트륨, 메틸셀룰로오스, 히도록시에틸셀룰로오스나트륨, 알긴산 나트륨, 크산탄검, 트라칸트검, 카라야검, 아라비아검, 로커스트빔검, 폴리비닐알코올, 폴리아크릴산 나트륨, 카르복시비닐 폴리머, 폴리비닐피롤리돈, 카르보폴, 실리카겔, 알루미늄실리카겔, 비검(bee gum), 라포나이트로부터 선택되는 증점제를 0.1 내지 5질량% 배합하고, 연치약(練齒磨) 조성물로서 조제된 것을 특징으로 하는 치약 조성물.In addition, dicalcium phosphate dihydrate, dicalcium phosphate anhydride, dibasic calcium phosphate, tricalcium phosphate, calcium pyrophosphate, calcium carbonate, aluminum hydroxide, alumina, magnesium carbonate, tertiary magnesium phosphate, insoluble sodium metaphosphate, 5 to 50% by mass of an abrasive selected from insoluble potassium metaphosphate, titanium oxide, zeolite, silicic anhydride, hydrous silicic acid, titanium silicate, zirconium silicate, and synthetic resin-based abrasives, sorbet, glycerin, propylene glycol, polyethylene glycol, 10 to 50 mass% of a viscous agent selected from xylitol, maltitol, lactol, 1,3-butylene glycol, polypropylene glycol, ethanol, modified ethanol, sugar alcohol reduced starch sugar saccharine, carrageenan, carboxymethyl cellulose sodium, Methyl cellulose, sodium hypogiethyl cellulose, sodium alginate, xanthan gum, tracant gum, karaya gum, gum arabic, locust beam gum 0.1-5 mass% of thickeners selected from polyvinyl alcohol, sodium polyacrylate, carboxyvinyl polymer, polyvinylpyrrolidone, carbopol, silica gel, aluminum silica gel, bee gum and laponite, (Iii) A toothpaste composition prepared as a composition.
KR1020087004645A 2005-12-15 2006-11-17 Toothpaste composition KR101331734B1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JPJP-P-2005-00361264 2005-12-15
JP2005361264 2005-12-15
PCT/JP2006/322952 WO2007069429A1 (en) 2005-12-15 2006-11-17 Toothpaste composition

Publications (2)

Publication Number Publication Date
KR20080074087A KR20080074087A (en) 2008-08-12
KR101331734B1 true KR101331734B1 (en) 2013-11-20

Family

ID=38162743

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020087004645A KR101331734B1 (en) 2005-12-15 2006-11-17 Toothpaste composition

Country Status (3)

Country Link
JP (1) JPWO2007069429A1 (en)
KR (1) KR101331734B1 (en)
WO (1) WO2007069429A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016068532A1 (en) * 2014-10-31 2016-05-06 주식회사 아모레퍼시픽 Exothermic oral composition

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5548969B2 (en) * 2007-09-14 2014-07-16 サンスター株式会社 Dentifrice composition
KR101013803B1 (en) * 2008-11-11 2011-02-14 (주)아모레퍼시픽 Oral composition for anticalculus
US8778312B2 (en) * 2009-04-01 2014-07-15 Colgate-Palmolive Company Densensitizing dentifrice exhibiting dental tissue antibacterial agent uptake
JP5572346B2 (en) * 2009-08-26 2014-08-13 花王株式会社 Oral composition
JP6007660B2 (en) * 2012-08-08 2016-10-12 ライオン株式会社 Oral composition and calculus formation inhibitor
JP6424087B2 (en) * 2014-12-26 2018-11-14 アース製薬株式会社 Oral composition
BE1025996A9 (en) 2018-01-19 2020-05-11 Hyloris Dev Sa ORAL TRANEXAMIC ACID SOLUTION
GB201811065D0 (en) 2018-07-05 2018-08-22 GlaxoSmithKline Consumer Healthcare UK IP Ltd Novel composition
GB201811061D0 (en) 2018-07-05 2018-08-22 GlaxoSmithKline Consumer Healthcare UK IP Ltd Novel composition
JPWO2022059642A1 (en) * 2020-09-17 2022-03-24

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH1149654A (en) * 1997-07-31 1999-02-23 Lion Corp Oral composition
JPH11506104A (en) * 1995-06-01 1999-06-02 コルゲート−パーモリブ・カンパニー Production of visually clear gel-like toothpaste

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4889712A (en) * 1986-03-20 1989-12-26 Colgate-Palmolive Company Anticalculus oral composition
JPH10182389A (en) * 1996-12-27 1998-07-07 Lion Corp Dentifrice composition
JP3978609B2 (en) * 2003-08-25 2007-09-19 ライオン株式会社 Oral composition and method for preventing precipitation of potassium lauryl sulfate in oral composition

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH11506104A (en) * 1995-06-01 1999-06-02 コルゲート−パーモリブ・カンパニー Production of visually clear gel-like toothpaste
JPH1149654A (en) * 1997-07-31 1999-02-23 Lion Corp Oral composition

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016068532A1 (en) * 2014-10-31 2016-05-06 주식회사 아모레퍼시픽 Exothermic oral composition
KR20160050814A (en) * 2014-10-31 2016-05-11 (주)아모레퍼시픽 Exothermic composition for oral use
KR102199880B1 (en) * 2014-10-31 2021-01-08 (주)아모레퍼시픽 Exothermic composition for oral use

Also Published As

Publication number Publication date
JPWO2007069429A1 (en) 2009-05-21
WO2007069429A1 (en) 2007-06-21
KR20080074087A (en) 2008-08-12

Similar Documents

Publication Publication Date Title
KR101331734B1 (en) Toothpaste composition
EP2600938B1 (en) Oral care compositions
JP2007145740A (en) Dentifrice composition
JP2003335646A (en) Dentifrice composition
JP2002047157A (en) Composition for oral cavity
KR20200093439A (en) Oral Stain Remover, Oral Stain Formation Inhibitor and Oral Composition
CN114502136B (en) Oral care spray compositions comprising hexametaphosphate salt
JP2011126840A (en) Composition for oral cavity
JP2007161657A (en) Dentifrice composition
JP3528389B2 (en) Oral composition
JP2004123684A (en) Dentifrice composition
JP2006104101A (en) Composition for oral cavity
KR102413711B1 (en) A toothpaste composition comprising hydrogen peroxide and a thickener in separate form
JPH01104004A (en) Composition for oral cavity application
JP3894110B2 (en) Whitening dentifrice composition
JPH05320032A (en) Composition for oral cavity application
US20060093562A1 (en) Use of sodium decyl sulfate in toothpaste
KR102582065B1 (en) A toothpaste composition comprising a chelating agent with supersaturated phosphate
CN114430678B (en) Oral care compositions comprising hexametaphosphate and pigment
KR100478211B1 (en) Whitening Toothpaste Composition
KR100494627B1 (en) Whitening toothpaste composition
KR102207880B1 (en) A toothpaste composition comprising a chelating agent with supersaturated phosphate
KR20030040411A (en) Oral composition
CN109890464B (en) Oral care compositions with increased whitening efficacy
KR100416416B1 (en) Tooth Paste-Composition Reporting A Moderate Gargling Time

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20161019

Year of fee payment: 4

FPAY Annual fee payment

Payment date: 20171018

Year of fee payment: 5

FPAY Annual fee payment

Payment date: 20181018

Year of fee payment: 6

FPAY Annual fee payment

Payment date: 20191017

Year of fee payment: 7